Patents by Inventor Sarena D. Horava

Sarena D. Horava has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMERS FOR DELIVERY OF FACTOR VIII AND/OR FACTOR IX
    Publication number: 20190275162
    Abstract: In some aspects, a composition comprising a pH-sensitive crosslinked copolymer of methacrylic acid and poly(ethylene glycol) monomethyl ether methacrylate and a therapeutic protein is provided. In some embodiments, the therapeutic protein is a high molecular weight protein such as factor VIII or factor IX. In some embodiments, the composition is orally administered to a patient to treat a disease or disorder such as, e.g., hemophilia.
    Type: Application
    Filed: March 13, 2019
    Publication date: September 12, 2019
    Inventors: Nicholas A. Peppas, Sarena D. Horava
  • Polymers for delivery of factor VIII and/or factor IX
    Patent number: 10265405
    Abstract: In some aspects, a composition comprising a pH-sensitive crosslinked copolymer of methacrylic acid and poly(ethylene glycol) monomethyl ether methacrylate and a therapeutic protein is provided. In some embodiments, the therapeutic protein is a high molecular weight protein such as factor VIII or factor IX. In some embodiments, the composition is orally administered to a patient to treat a disease or disorder such as, e.g., hemophilia.
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: April 23, 2019
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Nicholas A. Peppas, Sarena D. Horava
  • POLYMERS FOR DELIVERY OF FACTOR VIII AND/OR FACTOR IX
    Publication number: 20160136291
    Abstract: In some aspects, a composition comprising a pH-sensitive crosslinked copolymer of methacrylic acid and poly(ethylene glycol) monomethyl ether methacrylate and a therapeutic protein is provided. In some embodiments, the therapeutic protein is a high molecular weight protein such as factor VIII or factor IX. In some embodiments, the composition is orally administered to a patient to treat a disease or disorder such as, e.g., hemophilia.
    Type: Application
    Filed: November 17, 2015
    Publication date: May 19, 2016
    Inventors: Nicholas A. Peppas, Sarena D. Horava